Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study AZ3110865, a Study Comparing SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease

NCT00708552 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00708552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00708552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study AZ3110865, a Study Comparing SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
July 4, 2008
Completion date
March 9, 2010
Enrollment
576 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease